
A look ahead with mint Lesion 3.3
Mint Medical is pleased to announce the recent release of their software product version 3.3 of mint LesionTM which was completed during recent weeks.…

Mint Medical is pleased to announce the recent release of their software product version 3.3 of mint LesionTM which was completed during recent weeks.…

Shortly following the release of the new iRECIST- oncologic response criteria (Lancet Oncology, March 2017) the University Medical Center in Tübingen,…

Mrs. Kelie Luby will join Mint Medical’s team from January 2017 as new Vice President Clinical Trials Software and will be introduced at the upcoming…

Advances in oncology therapies, such as novel immune-related agents, require adapted and refined criteria and guidelines for the assessment and…

mint Lesion™ 3.3 features a novel data and knowledge modelling core that enables you to customize read procedures and reporting templates – or design…

Context-driven read procedures in mint Lesion™ facilitate the generation of well-structured data on a large scale. At RSNA 2016, Mint Medical presents…

4 days full of sun – there couldn’t be any better circumstances for Leipzig to present itself as new host of the German Radiology Congress.
Mint…

The ECR 2016 in Vienna achieved a new record in number of participants: 25.998 people visited the congress. Mint Medical also realized a personal best…